+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Diseases Drugs Market Research Reports

Oil and Gas Pipeline Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Oil and Gas Pipeline Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 125 Pages
  • Global
From
Offshore Pipeline Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Offshore Pipeline Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 125 Pages
  • Global
From
Pipeline Maintenance Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Pipeline Maintenance Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • February 2022
  • 125 Pages
  • Global
From
Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 71 Pages
  • Global
From
Hepatitis A Virus Cellular Receptor 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 64 Pages
  • Global
From
Respiratory Syncytial Virus Fusion Protein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Respiratory Syncytial Virus Fusion Protein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 84 Pages
  • Global
From
Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 72 Pages
  • Global
From
Viral Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Viral Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 40 Pages
  • Global
From
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 86 Pages
  • Global
From
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
Glycoprotein 41 (gp41) - Pipeline Review, H2 2020 - Product Thumbnail Image

Glycoprotein 41 (gp41) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Genital Herpes - Pipeline Review, H2 2020 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 123 Pages
  • Global
From
Bacterial Vaginosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Bacterial Vaginosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 75 Pages
  • Global
From
Toxoplasmosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Toxoplasmosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 48 Pages
  • Global
From
Global Trypanosomiasis Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Trypanosomiasis Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Zika Virus Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Zika Virus Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Broad Spectrum Bacterial Infections Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Broad Spectrum Bacterial Infections Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Community-Acquired Pneumonia Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Community-Acquired Pneumonia Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global HIV Treatment Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global HIV Treatment Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from common colds to more serious conditions such as HIV/AIDS, malaria, and tuberculosis. The market is highly competitive, with many companies vying for a share of the market. Infectious Diseases Drugs are typically developed through a combination of research and development, clinical trials, and regulatory approval. Companies in the market must also ensure that their products are safe and effective for use in humans. Some of the major players in the Infectious Diseases Drugs market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Johnson & Johnson. These companies are involved in the development and production of a wide range of drugs used to treat infectious diseases. Show Less Read more